These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 38303912)

  • 1. Nanotechnology-based non-viral vectors for gene delivery in cardiovascular diseases.
    Jiao L; Sun Z; Sun Z; Liu J; Deng G; Wang X
    Front Bioeng Biotechnol; 2024; 12():1349077. PubMed ID: 38303912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in nonviral vectors for gene delivery.
    Guo X; Huang L
    Acc Chem Res; 2012 Jul; 45(7):971-9. PubMed ID: 21870813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
    Sainz-Ramos M; Gallego I; Villate-Beitia I; Zarate J; Maldonado I; Puras G; Pedraz JL
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Non-Viral Vectors in Drug Delivery and Gene Therapy.
    Ren S; Wang M; Wang C; Wang Y; Sun C; Zeng Z; Cui H; Zhao X
    Polymers (Basel); 2021 Sep; 13(19):. PubMed ID: 34641123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in nanotechnology approaches for non-viral gene therapy.
    Jiang Y; Fan M; Yang Z; Liu X; Xu Z; Liu S; Feng G; Tang S; Li Z; Zhang Y; Chen S; Yang C; Law WC; Dong B; Xu G; Yong KT
    Biomater Sci; 2022 Dec; 10(24):6862-6892. PubMed ID: 36222758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral vectors for gene transfer: a review of their use in the treatment of human diseases.
    Walther W; Stein U
    Drugs; 2000 Aug; 60(2):249-71. PubMed ID: 10983732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy Based on Lipid Nanoparticles as Non-viral Vectors for Glioma Treatment.
    Luiz MT; Tofani LB; Araújo VHS; Di Filippo LD; Duarte JL; Marchetti JM; Chorilli M
    Curr Gene Ther; 2021; 21(5):452-463. PubMed ID: 33390137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development of Functional Non-Viral Vectors for Gene Delivery.
    Patil S; Gao YG; Lin X; Li Y; Dang K; Tian Y; Zhang WJ; Jiang SF; Qadir A; Qian AR
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31690044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery.
    Wang H; Qin L; Zhang X; Guan J; Mao S
    J Control Release; 2022 Dec; 352():970-993. PubMed ID: 36372386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a new non-viral vector for transfection: Eudragit nanoparticles for the delivery of a DNA plasmid.
    Gargouri M; Sapin A; Bouli S; Becuwe P; Merlin JL; Maincent P
    Technol Cancer Res Treat; 2009 Dec; 8(6):433-44. PubMed ID: 19925027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging non-viral vectors for gene delivery.
    Wang C; Pan C; Yong H; Wang F; Bo T; Zhao Y; Ma B; He W; Li M
    J Nanobiotechnology; 2023 Aug; 21(1):272. PubMed ID: 37592351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
    Ediriweera GR; Chen L; Yerbury JJ; Thurecht KJ; Vine KL
    Mol Pharm; 2021 Jun; 18(6):2142-2160. PubMed ID: 34010004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sight on the current nanoparticle-based gene delivery vectors.
    Dizaj SM; Jafari S; Khosroushahi AY
    Nanoscale Res Lett; 2014; 9(1):252. PubMed ID: 24936161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Nanomaterials for Gene Delivery-A Review.
    Riley MK; Vermerris W
    Nanomaterials (Basel); 2017 Apr; 7(5):. PubMed ID: 28452950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, preparation and application of nucleic acid delivery carriers.
    Yang J; Liu H; Zhang X
    Biotechnol Adv; 2014; 32(4):804-17. PubMed ID: 24239630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
    Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
    J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-linked lipid-based nanoparticle for targeted gene delivery.
    Hattori Y; Maitani Y
    Curr Drug Deliv; 2005 Jul; 2(3):243-52. PubMed ID: 16305426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral vectors for cardiovascular gene therapy applications: a clinical and industry perspective.
    Jt S; M H; Wam B; Ac B; Sa N
    J Mol Med (Berl); 2022 Jun; 100(6):875-901. PubMed ID: 35606652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cell fate following non-viral gene transfection strongly depends on the choice of delivery vector.
    Gonzalez-Fernandez T; Sathy BN; Hobbs C; Cunniffe GM; McCarthy HO; Dunne NJ; Nicolosi V; O'Brien FJ; Kelly DJ
    Acta Biomater; 2017 Jun; 55():226-238. PubMed ID: 28363788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic nanoemulsions as nucleic acids delivery systems.
    Teixeira HF; Bruxel F; Fraga M; Schuh RS; Zorzi GK; Matte U; Fattal E
    Int J Pharm; 2017 Dec; 534(1-2):356-367. PubMed ID: 29038065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.